Microenvironmental Changes in Mediastinal Fat-associated Lymphoid Clusters and Lungs in Early and Late Stages of Metastatic Lung Cancer Induction

The prognosis of metastatic lung melanoma (MLM) has been reported to be poor. An increasing number of studies have reported the function of several immune cells in cancer regression. Although the function of mediastinal fat-associated lymphoid clusters (MFALCs) in the progression of inflammatory lung lesions has been previously reported, the association between MLM progression and MFALCs development has remained unexplored. Herein, we compared the microenvironmental changes in the lungs and MFALCs among phosphate-buffered saline (PBS) and cancer groups at early (1 week) and late (2 weeks) stages following the intravenous injection of B16-F10 melanoma cells into C57BL/6 mice. Except for lung CD4(+) helper T-cells and Iba1(+) macrophage populations of early stage, we observed a significant increase in the proliferating and immune cell (CD20(+) B-lymphocytes, CD3(+) T-lymphocytes, CD8(+) cytotoxic T-cells, CD16(+) natural killer (NK) cells populations, area of high endothelial venules, and lung lymphatic vessels in cancer groups at both the stages as compared with the PBS groups. Furthermore, a significant positive correlation was observed between immune cell populations in MFALCs and the lungs (B- and T-lymphocytes, and NK cells in both stages). Collectively, our findings suggest a promising cancer therapeutic strategy via targeting immune cells in MFALCs.

Automated summary

By comparing the changes in the lungs and mediastinal fat-associated lymphoid clusters (MFALCs) between patients with metastatic lung melanoma (MLM) and healthy individuals, it was found that MLM patients had a significant increase in immune cell populations in MFALCs, which may be associated with the progression of MLM. Therefore, targeting immune cells in MFALCs could be a promising therapeutic strategy for cancer treatment.